Compare GMED & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | MEDP |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.7B |
| IPO Year | 2012 | 2016 |
| Metric | GMED | MEDP |
|---|---|---|
| Price | $87.54 | $412.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 12 |
| Target Price | $100.42 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 950.4K | 442.5K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | 20.98 |
| EPS | 3.92 | ★ 4.28 |
| Revenue | ★ $2,938,931,000.00 | N/A |
| Revenue This Year | $11.13 | $13.19 |
| Revenue Next Year | $6.28 | $7.75 |
| P/E Ratio | ★ $23.16 | $95.74 |
| Revenue Growth | ★ 16.65 | N/A |
| 52 Week Low | $51.79 | $284.10 |
| 52 Week High | $101.40 | $628.92 |
| Indicator | GMED | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 34.96 |
| Support Level | $85.01 | $410.09 |
| Resistance Level | $87.77 | $485.13 |
| Average True Range (ATR) | 2.85 | 17.87 |
| MACD | -0.58 | -12.67 |
| Stochastic Oscillator | 0.30 | 25.06 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.